FMC Corp's Q3 revenue drops 80%, hurt by commercial actions and weak demand

By Reuters News


Overview

  • US agricultural sciences firm's Q3 revenue fell sharply, missing analyst expectations

  • Q3 adjusted EBITDA was negative and missed analyst expectations

  • Company says results reflect commercial actions and weaker demand


Outlook

  • FMC sees Q4 revenue excluding India at $1.04 bln to $1.14 bln

  • Company expects Q4 adjusted EBITDA of $210 mln to $230 mln

  • FMC forecasts Q4 adjusted EPS of $0.56 to $0.70


Result Drivers

  • COMMERCIAL ACTIONS - Co said Q3 results were heavily impacted by pricing and rebate changes in North America and adjustments on high-priced products held by channel customers

  • LOWER VOLUMES - Co said channel customers in key markets reduced replenishment orders, leading to a 21% volume decline

  • PRICE DECLINES - Co said Q3 prices fell 2% compared to prior year


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Miss

$106 mln

$859.59 mln (13 Analysts)

Q3 Net Loss

$2.07 bln

Q3 Adjusted EBITDA

Miss

-$559 mln

$127.73 mln (13 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 14 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the agricultural chemicals peer group is "buy."

  • Wall Street's median 12-month price target for FMC Corp is $9.00, about 101.3% above its October 28 closing price of $4.47

  • The stock recently traded at 3 times the next 12-month earnings vs. a P/E of 6 three months ago


Reuters Recommended Reads

  • Oct 29 - AGCO cites "weakest global industry demand in over a decade" for Q3 sales decline

  • Oct 28 - John B Sanfilippo Q1 sales fall on lower selling prices

  • Oct 29 - Bunge Q3 profit beats on oilseed processing strength


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.